FindTrial
Sign In

Clinical Classification of COPD with Invasive Pulmonary Aspergillosis

Clinical Classification of COPD with Invasive Pulmonary Aspergillosis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500108905
Enrollment
Unknown
Registered
2025-09-09
Start date
2025-08-01
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

Fulminant type:None
Tuberculosis-like type:None
Heart failure-like type:None
Asthma-like type:None
Tumor-like type:None
Pneumonia-like type:None

Sponsors

Sun Yat-sen Memorial Hospital of Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Patients with GOLD grade III–IV COPD (as per GOLD guidelines, FEV1/FVC < 0.7) complicated by invasive pulmonary aspergillosis (meeting Bulpa criteria for proven, probable, or putative IPA).

Exclusion criteria

Exclusion criteria: 1. Merged active pulmonary tuberculosis, lung cancer, and other invasive fungal infections; 2. Hematological malignancies, solid organ transplants, HIV infections; 3. Missing medical records >30% of key data (such as lung CT or X-ray, etc.).

Design outcomes

Primary

MeasureTime frame
Partial pressure of arterial carbon dioxide;—

Secondary

MeasureTime frame
White blood cell count;Neutrophil percentage;Oxygenation Index;—

Countries

China

Contacts

Public ContactShi jianting

Shenshan Medical Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University

shijt5@mail.sysu.edu.cn+86 13570903906

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026